Data

Click on Protocol Number of interest to view study-related documentation or download data files. (DTMC data files are under development.)
Division Study Number Title Investigator(s) Release Date
CTN NIDA-CTN-0079 Emergency Department Connection to Care with Buprenorphine for Opioid Use Disorder (ED-CONNECT) John Rotrosen, M.D., Kathryn Hawk, M.D., M.H.S., Ryan McCormack, M.D. Nov 04, 2024
CTN NIDA-CTN-0081 Capturing Opioid Use Disorder Electronically & Patient Reported Outcomes (CODE-PRO) Arjun Krishna Venkatesh, MD, MBA, MHS, Kathryn Hawk, M.D., M.H.S., Richard Andrew Taylor, MD, MHS Dec 06, 2024
CTN NIDA-CTN-0093 Validation of a Community Pharmacy-Based Prescription Drug Monitoring Program Risk Screening Tool Gerald Cochran, PhD, T. John Winhusen, Ph.D. Apr 13, 2023
CTN NIDA-CTN-0095A2 Reducing Stigma toward People with Opioid Use Disorder among Primary Care Clinicians Stephanie Hooker, Ph.D., M.P.H., Rebecca Rossom, M.D., M.S., A. Lauren Crain, Ph.D., Gavin Bart, Ph.D., M.D. May 24, 2024
CTN NIDA-CTN-0097 Surmounting Withdrawal to Initiate Fast Treatment With Naltrexone (SWIFT) Adam Bisaga, M.D., Edward V. Nunes, M.D. Feb 11, 2025
DTMC NIDA-CTO-0001 Phase 2, Double-Blind, Placebo-Controlled Trial Of Reserpine For The Treatment Of Cocaine Dependence Eugene Somoza, M.D. Dec 04, 2014
DTMC NIDA-CTO-0002 Safety Evaluation Of Cocaine Treatment Medication, Modafinil: Interactions With Intravenous Cocaine Robert J. Malcolm, M.D., C. Lindsay DeVane, Pharm.D. Aug 01, 2016
DTMC NIDA-CTO-0003 Assessment Of Potential Interactions Between Intravenous Cocaine And Tolcapone Thomas F. Newton, M.D. Aug 01, 2016
DTMC NIDA-CTO-0004 Assessment Of Potential Interactions Between Intravenous Methamphetamine And Oral Selegiline Thomas F. Newton, M.D. Aug 01, 2016
DTMC NIDA-CTO-0005 Double-Blind, Placebo-Controlled Trial Of Ondansetron For The Treatment Of Cocaine Dependence John D. Roache, Ph.D. Aug 01, 2016